Actavis rejected $15 billion offer from Mylan - source
May 14, 2013 at 19:13 PM EDT
NEW YORK, May 14 (Reuters) - Actavis Inc received and rejected a takeover offer from Mylan Inc last week that valued the generic drugmaker at more than $15 billion, a person familiar with the situation told Reuters on Tuesday.
